SLC5A2 and hydrops fetalis: Findings were integrated using joint displays.<h4>Results</h4>Of 312 physicians surveyed (214 treating, 98 insurance), treating physicians showed moderate-to-good knowledge and favorable attitudes toward SGLT2 inhibitors in HF, yet initiation rates were low.